A co-operative evaluation of different methods of detecting BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on second-line dasatinib or nilotinib therapy after failure of imatinib
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2015 ◽
Vol 21
(2)
◽
pp. 114-122
◽
2012 ◽
Vol 16
(11)
◽
pp. 1317-1321
◽
Keyword(s):